Many investors avoid quality businesses that have already doubled or tripled, assuming they've missed the opportunity. The contrarian reality is that these moves often signal the beginning of a compounding story, not the end.
Outsized returns come from identifying businesses that can grow revenue and free cash flow (FCF) without heavy reinvestment, then holding them as compounding works over time.
Below, we'll explain why paying up for quality compounders often beats buying mediocre businesses at bargain prices, and how to evaluate whether a stock that's already risen substantially can still generate strong returns.
Why Quality Beats Starting Price
The ideal business grows revenue and FCF without requiring heavy reinvestment. Royalty or franchise software economics represent this model at its best.
By "royalty or franchise economics," we mean businesses that collect recurring fees from a large customer base without needing to rebuild the product/service for each customer, similar to how a franchisor collects ongoing royalties without operating each location.
Software businesses fit this model when the product is durable, monetizable across many customers, and has pricing power or inflation-linked pricing. Improving margins, pricing power, and low incremental capital needs result in rising FCF per share (FCF/S).
Math Behind Starting Multiples
Valuation is about what you'll receive in future FCF relative to the multiple you pay today. Paying a premium makes sense for an asset that can compound FCF at 2-3x the market rate and prove more durable.
The key question is not whether a stock looks expensive today. It's whether the business can compound cash flows fast enough that today's multiple becomes meaningless in 5 or 10 years.
For instance, a business trading at 30x FCF that compounds at 20% annually will trade at just 12x its future FCF in 5 years (30x / 2.49, where 2.49 is the cumulative growth factor from 20% annual growth). Meanwhile, a business at 15x that compounds at 5% annually will still trade at 12x its future FCF after 5 years (15x / 1.28):
The faster compounder justifies the higher starting multiple because time and compounding do the heavy lifting. You also need to weigh the risks required to achieve that compounding, which brings us to business quality.
What Buffett's Winners Teach Us
Warren Buffett's track record illustrates this principle. Many investors view Buffett's approach as simply buying cheap and selling when expensive. They underemphasize his focus on business quality.
Buffett's biggest winners involved buying businesses with predictable, forecastable revenues where he was willing to pay a premium for exceptional operators. Washington Post, Coca-Cola, Gillette, and Apple fit this description. His mistakes tend to be in cyclical, hard-to-predict businesses like Precision Castparts.
Get Our 50-Question Stock Analysis Checklist!
After researching hundreds of stocks, we built this 50-question checklist to guide your analysis and help you avoid costly mistakes.
Download ChecklistBusiness quality, leadership, and predictability enable long holding periods and high compounding. These attributes are worth paying up for because they reduce the risk that your compounding assumptions prove wrong.
When to Bet on Reinvestment Stories
Exceptions exist. Early Amazon reinvested heavily in operations (showing up as OpEx rather than CapEx) rather than reporting positive FCF. The business burned cash for years while building infrastructure for future dominance.
Still, the preference is for simpler, more straightforward FCF stories. Sometimes it's better to see the story start working before committing, to see cash flow following price rather than betting on a promise.
Businesses that require continuous heavy reinvestment to maintain growth represent a different risk profile than those that can grow with minimal incremental capital.
Related: How to Estimate the Downside Risk of a Stock
Constellation Software
Constellation Software (TSX: CSU) demonstrates why buying quality after substantial price appreciation can still work.
The company acquires and operates vertical market software businesses serving niche industries. These businesses provide mission-critical software to specific sectors like government services, healthcare clinics, construction companies, and other specialized markets. Each acquired business maintains its own management team and operates independently under Constellation's decentralized structure.
From Oct. 2020 to Oct. 2025, Constellation's stock delivered a 22% annual return, rising 175% over that 5-year period. Many investors would view this performance as a sign they've missed the opportunity. However, the financial results indicate the compounding may not be over.
Revenue and Cash Flow Growth
Constellation's revenue and cash generation both expanded significantly from 2020 to 2024:
The revenue composition explains why future cash flows are easier to forecast:
Maintenance and recurring revenue represents ongoing fees customers pay to continue using the software (annual renewals, support contracts, subscriptions). This revenue repeats each period with high retention rates, making future cash flows more predictable than businesses dependent on one-time sales.
Capital Efficiency
Constellation demonstrates exceptional capital efficiency through minimal reinvestment requirements:
The business converts nearly all operating cash flow into distributable cash after minimal maintenance capital requirements. This represents the ideal software economics where growth doesn't require proportional capital investment.
Capital Structure
Although Constellation's debt profile increased significantly from 2020 to 2024, the business generates ample cash flow to service that debt:
The cash flow to debt ratio declined from 1.14x in 2020 to 0.48x in 2024 as the company added leverage. While debt generally grew faster than operating cash flow, the 0.48x ratio remains manageable given the predictability of recurring revenues and strong FCF conversion.
Why the Stock Can Still Work
Despite rising 175% from 2020 to 2025, Constellation's FCF growth tracked the stock price appreciation closely, meaning the business didn't become meaningfully more expensive relative to its cash generation.
FCF grew at ~16% annually from 2020 to 2024 ($1,161M to $2,129M). The stock compounded at 22% annually over a similar period, with the P/FCF multiple expanding from 23.7x in 2020 to 30.8x in 2024.
In FY 2024, the company generated $2,129M in FCF. At the current market cap of $35B, this represents a P/FCF multiple of 16.4x ($35B / $2,129M).
If Constellation maintains 10-12% annual FCF growth over the next 5 years (e.g., via organic growth and acquisitions), the business will generate $3,400M to $3,700M in annual FCF by 2029 ($2,129M × 1.61 = $3,428M at 10% growth; $2,129M × 1.76 = $3,747M at 12% growth).
An investor buying today at 16.4x would own a business trading at just ~9-10x its 2029 FCF ($35B / $3,400M = 10.3x; $35B / $3,700M = 9.5x), assuming no multiple expansion. If the business continues demonstrating its durability and capital allocation discipline, that multiple could expand rather than contract.
The Bottom Line
Quality and predictability often trump bargain valuations because low multiples often exist for good reasons.
An overleveraged balance sheet, secular decline, or cyclical stress can justify a low valuation. You're not getting a bargain if the business deteriorates faster than you expected.
If a stock has doubled or tripled, you haven't necessarily missed it. The compounding story may be just beginning. What matters is whether the underlying business continues generating strong FCF growth that makes today's multiple irrelevant over time.
